IGF1 and PPARG polymorphisms are associated with reduced estimated glomerular filtration rate in a cohort of children and adolescents with type 1 diabetes.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 06 10 2022
accepted: 03 06 2023
medline: 23 8 2023
pubmed: 20 6 2023
entrez: 20 6 2023
Statut: ppublish

Résumé

Several genetic loci have been associated with diabetic nephropathy; however, the underlying genetic mechanisms are still poorly understood, with no robust candidate genes identified yet. We aimed to determine whether two polymorphisms, previously associated with renal decline, influence kidney impairment evaluating their association with markers of renal function in a pediatric population with type 1 diabetes (T1D). Renal function was evaluated by glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR) in a cohort of pediatric subjects with T1D (n = 278). Risk factors for diabetes complications (diabetes duration, blood pressure, HbA1c) were assessed. The IGF1 rs35767 and PPARG rs1801282 SNPs were genotyped by TaqMan RT-PCR system. An additive genetic interaction was calculated. Association analysis between markers of renal function and both SNPs or their additive interaction were performed. Both SNPs showed a significant association with eGFR: the A allele of rs35767 or the C allele of rs1801282 were associated to reduced eGFR compared to G alleles. Multivariate regression analysis adjusted for age, sex, z-BMI, T1D duration, blood pressure and Hba1c values showed that the additive genetic interaction was independently associated with lower eGFR (β = -3.59 [-6.52 to -0.66], p = 0.017). No associations were detected between SNPs, their additive interaction and ACR. These results provide new insight into the genetic predisposition to renal dysfunction, showing that two polymorphisms in IGF1 and PPARG genes can lead to a reduction in renal filtration rate leading these patients to be exposed to a higher risk of early renal complications.

Identifiants

pubmed: 37338602
doi: 10.1007/s00592-023-02128-6
pii: 10.1007/s00592-023-02128-6
pmc: PMC10442246
doi:

Substances chimiques

PPAR gamma 0
Glycated Hemoglobin 0
IGF1 protein, human 0
Insulin-Like Growth Factor I 67763-96-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1351-1358

Informations de copyright

© 2023. The Author(s).

Références

PPAR Res. 2010;2010:698730
pubmed: 20613959
Clin J Am Soc Nephrol. 2009 Nov;4(11):1832-43
pubmed: 19820136
Kidney Dis (Basel). 2018 Nov;4(4):226-237
pubmed: 30574499
Clin Exp Nephrol. 2013 Dec;17(6):866-71
pubmed: 23543049
Diabetes. 2002 Aug;51(8):2341-7
pubmed: 12145143
Oncotarget. 2017 May 16;8(20):32398-32406
pubmed: 28415730
Diabetologia. 2012 Sep;55(9):2386-93
pubmed: 22643932
Kidney Dis (Basel). 2021 Sep 03;8(1):93-101
pubmed: 35224010
Mol Genet Metab. 2008 Jul;94(3):347-51
pubmed: 18467141
Clin J Am Soc Nephrol. 2007 Nov;2(6):1306-16
pubmed: 17942768
PLoS One. 2013 Dec 31;8(12):e85483
pubmed: 24392014
J Hypertens. 2016 Oct;34(10):1887-920
pubmed: 27467768
Curr Opin Nephrol Hypertens. 2012 Jan;21(1):97-105
pubmed: 22143250
Diabetologia. 2018 Jul;61(7):1650-1661
pubmed: 29671030
Diabetes Metab Syndr. 2015 Jan-Mar;9(1):46-50
pubmed: 25450819
Am J Kidney Dis. 2015 Feb;65(2):327-36
pubmed: 25151409
J Diabetes Investig. 2020 Jul;11(4):923-929
pubmed: 31912623
Genet Test Mol Biomarkers. 2012 May;16(5):429-34
pubmed: 22103651
Biochem Biophys Res Commun. 2000 Feb 5;268(1):178-82
pubmed: 10652233
Br J Cancer. 2006 Jan 30;94(2):299-307
pubmed: 16404426
Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1123-1129
pubmed: 31336454
EBioMedicine. 2016 Apr;6:162-170
pubmed: 27211558
Wien Klin Wochenschr. 2012 Oct;124(19-20):671-7
pubmed: 22987045
Diagn Pathol. 2013 Jul 15;8:118
pubmed: 23856170
Clin Chim Acta. 2022 Jan 1;524:146-153
pubmed: 34767792
BMC Nephrol. 2021 Jun 2;22(1):207
pubmed: 34078313
Diabetes Res Clin Pract. 2018 Oct;144:137-143
pubmed: 30153470
Metabolism. 2015 Dec;64(12):1629-39
pubmed: 26455399
Diabetes. 2009 Jul;58(7):1651-8
pubmed: 19401416
Acta Paediatr Suppl. 2006 Apr;450:38-46
pubmed: 16817677
Cells. 2021 Nov 30;10(12):
pubmed: 34943879
Hypertens Res. 2009 May;32(5):411-8
pubmed: 19282863
Adv Chronic Kidney Dis. 2014 May;21(3):273-80
pubmed: 24780455
World J Diabetes. 2021 Oct 15;12(10):1765-1777
pubmed: 34754377
Diabetes Care. 2012 Jun;35(6):1388-93
pubmed: 22619290
Growth Horm IGF Res. 2019 Oct - Dec;48-49:1-4
pubmed: 31352157
J Clin Endocrinol Metab. 2014 Mar;99(3):800-7
pubmed: 24423327
Diabetes Metab. 2019 Oct;45(5):494-497
pubmed: 29540294

Auteurs

Chiara Zusi (C)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy. chiara.zusi@univr.it.

Marco Rioda (M)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy.

Alice Maguolo (A)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy.

Federica Emiliani (F)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy.

Ilaria Unali (I)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy.

Silvia Costantini (S)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy.

Massimiliano Corradi (M)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy.

Giovanna Contreas (G)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy.

Anita Morandi (A)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy.

Claudio Maffeis (C)

Department of Surgery, Dentistry, Gynecology and Pediatrics, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera, Università di Verona, Piazzale A. Stefani, 1, 37126, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH